Last verified: 17 days ago
Innoslim
Also known as: Astragalus membranaceus extract, Panax notoginseng extract, NovaBay Innoslim, polysaccharide-saponin blend
Evidence under review. — Not yet rated
Proprietary plant extract blend marketed for weight management. Very limited independent clinical evidence.
-
What it does
Innoslim is a patented blend of Astragalus membranaceus and Panax notoginseng plant extracts. It is marketed to support weight management by influencing hormones like adiponectin and AMPK pathways...
-
Evidence quality
Evidence base hasn't been formally rated yet. See research below.
-
Clinical dose
250 mg daily based on manufacturer claims; No established clinical dose from provided studies
-
Found in
What the Science Says
Innoslim is a patented blend of Astragalus membranaceus and Panax notoginseng plant extracts. It is marketed to support weight management by influencing hormones like adiponectin and AMPK pathways that regulate fat and glucose metabolism. The available published research is extremely limited, and most supporting data appears to come from manufacturer-funded or unpublished sources rather than independent peer-reviewed clinical trials.
What It Doesn't Do
Not proven to cause meaningful fat loss on its own. No independent large-scale clinical trials confirm the weight loss claims. The hormone-signaling mechanisms are largely theoretical in humans at this dose. Don't expect results comparable to prescription weight-loss drugs. Marketing language around 'activating AMPK' is not backed by robust human evidence.
Absorption & Bioavailability
Unknown — no pharmacokinetic data from provided studies. The proprietary extraction process is claimed to enhance bioavailability, but this has not been independently verified.
Red Flags to Watch For
- Only one toxicology paper indexed on PubMed — virtually no independent clinical trial data available
- Proprietary blend means exact ratios of active compounds are not disclosed to consumers
- Most efficacy claims appear to originate from manufacturer-sponsored data, not independent research
- 39 registered supplement products contain it, suggesting heavy commercial use despite weak evidence
- AMPK and adiponectin pathway claims are mechanistically plausible but unproven at typical supplement doses in humans
Products Containing Innoslim
See how Innoslim is used in these analyzed products:
Frequently Asked Questions
What does Innoslim do?
Proprietary plant extract blend marketed for weight management. Very limited independent clinical evidence.
What is the effective dose of Innoslim?
250 mg daily based on manufacturer claims; No established clinical dose from provided studies
Is Innoslim safe?
Only one toxicology paper indexed on PubMed — virtually no independent clinical trial data available
What doesn't Innoslim do?
Not proven to cause meaningful fat loss on its own.
Research Sources
- General knowledge
- Limited published research available — 1 PubMed-indexed paper with no abstract; manufacturer claims not independently verified
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-05-25